白花水竹草（Tradescantia albiflora Kunth）降低大鼠血中 尿酸值、抗氧化性及其毒性探討

The Study of Chinese Medicinal Herb Tradescantia albiflora Kunth on Rat Plasma Uric Acid Reduction, Antioxidantion and Toxicity

莊雅玲(Ya-Ling Chuang)

指導教授 ： 郭宗甫

國立臺灣大學/生物資源暨農學院/獸醫學研究所/碩士(2005年)

https://doi.org/10.6342/NTU.2005.00356

摘要

血中尿酸值會藉由尿酸的過度製造或排泄過低而增高，並造成高尿酸血症（hyperuricemia）。高尿酸血症的發生，可能引起尿酸鹽沈積於關節而引發疼痛性炎症反應而造成痛風，且已有許多報告指出其和動脈硬化、高血壓、心血管疾病、糖尿病及腎臟疾病相關。黃嘌呤酶會將次黃嘌呤及黃嘌呤代謝成尿酸，故其為引發高尿酸血症之關鍵酵素。活性氧屬除已知會造成脂質過氧化而導致食物變性外，也有許多文獻指出其與慢性心衰竭、老化及呼吸性窘迫症候群有關。而由於藥品使用的副作用及保健食品的盛行，使得自天然物中找尋無副作用或副作用較低的有效成分之研究受到重視，其中又以黃嘌呤酶抑制劑及抗氧化劑等為目前研究重心。而雖然大部分的天然物是安全的，但長期性且大量的服用是否會影響肝腎功能，或懷孕動物高劑量的服用是否會影響胚胎發育或導致胎兒畸形，仍須實驗進行探究。因此本實驗選用傳統中醫藥用於降低血中尿酸值之植物白花水竹草，進行其萃取物之生物活性試驗及毒性試驗。
新鮮白花水竹草降低血中尿酸值試驗是使用尿酸酶抑制劑oxonate，以腹腔注射方式製成高尿酸血症模式大鼠，在分別口服白花水竹草之葉粗萃液、莖粗萃液或磷酸緩衝液後，每隔90分鐘採取血液進行血液學及血液生化學檢測，並同時監測血壓變化。萃取物降低血中尿酸值試驗是使用高尿酸血症模式大鼠，分別口服由白花水竹草乾燥葉片以正己烷、乙醯乙脂、丁醇及蒸餾水所萃取出之HE、EAE、BE及WE產物，並每隔30分鐘採血進行尿酸值檢測。促尿酸排泄試驗以高尿酸血症模式大鼠，分別口服磷酸緩衝液或WE產物，並於口服後之30、90、150及210分鐘採取尿液，進行尿酸值檢測。DPPH自由基清除效力及抗氧化活性試驗是以不同濃度的四種分劃層萃取物與試劑反應後，分別於517 nm及500 nm進行吸光值檢測。另外分別於懷孕第1~4天或8~11天口服50倍降低血中尿酸值之有效劑量的白花水竹草乾葉（625 mg/kg），以瞭解其是否影響胎兒著床及致畸形。亞急性毒性試驗則連續28天使大鼠口服10倍降低血中尿酸值之有效劑量的白花水竹草乾葉（125 mg/kg），並以血液學、血液生化學及組織病理學評估毒性。
研究結果顯示新鮮白花水竹草葉片可降低血中尿酸值，其四種分劃層萃取產物也具同樣效果，且最後一個評估時間點以WE之降低血中尿酸值能力最佳。四種分劃層萃取產物也可抑制黃嘌呤酶，且同樣以WE之抑制力最強。促尿酸排泄試驗結果顯示WE無促進尿酸排泄效力。DPPH自由基清除試驗及抗氧化活性試驗，則以BW之抗氧化力最強。毒性試驗方面，結果顯示懷孕期間口服50倍降低血中尿酸值之白花水竹草乾葉不會造成懷孕母鼠之胚胎著床、致畸形性及耗損等影響；亞急性毒性試驗之血液學檢測結果顯示Hb、HCT及RBC值顯著上升（p＜0.05），血液生化學檢測結果顯示ALKP及BUN值顯著下降（p＜0.05）。組織病理學檢查結果顯示肝細胞腫脹及輕微膽管增生，其餘肺臟、脾臟及腎臟則無顯著變化。
綜合本研究之實驗結果，可以得到以下結論：白花水竹草可藉由抑制黃嘌呤酶而降低血中尿酸值，且可清除自由基及預防脂質過氧化而達抗氧化之功能。雖懷孕期間口服五十倍降低血中尿酸值劑量之白花水竹草並不會影響懷孕母鼠之著床，也不會造成胎仔出現畸形或耗損之情形，但28天且高量的口服白花水竹草會造成肝細胞腫脹及輕微膽管增生情形，表示白花水竹草也許不適合長期且大量的服用。

關鍵字

高尿酸血症 ； 黃嘌呤酶抑制劑 ； 白花水竹草 ； 抗氧化劑

並列摘要

Serum uric acid was be elevated because of urate overproduction and/or underexcretion, and it will cause hyperuricemia. Hyperuricemia may cause the deposition of uric acid in joints and lead to painful inflammation. There were also many researches indicated that hyperuricemia was related with atherosclerosis, hypertension, cardiovascular diseases, diabetes mellitus and renal disease. Xanthine oxidase (XO) will catalyze the hypoxanthine and xanthine to uric acid, which is the main enzyme in hyperuricemia. The current agent used to treat the hyperuricemia is XO inhibitor, but the allopurinol used in clinical will cause side effect and prompt the development of XO inhibitor. Reactive oxygen species (ROS) had been known to cause lipid peroxidation which induce nutritional degradation of food products. ROS were also related to chronic cardiac failure, ageing, acute respiratory distress syndrome. Because of the side effect of the medicine and the fashion of healthy food, many scholars start to pay attention to the research of non side effect or low side effect compound from traditional medicine. Among these researches, most scholars are focusing on XO inhibitor agents and antioxidant. Although the natural antioxidant is safe in general, daily usage may cause potential complication, for example it may affect the function of liver and kidney or it may also impact on fertilized egg implantation and fetal organogenesis when the rats were oral administration with high dosage during the period of pregnancy. Therefore this study was investigated to the bioactivity and toxicity of extractive from the leaves of Tradescantia albiflora Kunth, which is a Chinese medicine plant to reduce serum uric acid level on rat.
The experiment was designed to use oxonate to be injected intraperitonelly to induce rat in hyperuricemic model, then these rats were oral administration crude extractive from the leaves, stem of T. albiflora or PBS respectively. Blood samples were collected to process hematology and biochemistry study every 90 mins, and monitored the change of blood pressure in the same time. We have used hexane, ethyl acetate, butanol and distilled water to extract the dry leaves of T. albiflora then got hexane extractive (HE), ethyl acetate extractive (EAE), butanol extractive (BE) and water extractive (WE) respectively. The experiment of decrease the plasma uric acid (PUA) level with extractives used by rat in hyperuricemic model to oral administration with HE, EAE, BE and WE extractive respectively, and bloods samples were collected to process PUA test every 30 mins.
The experiments of eliminated uric acid were utilized by rat in hyperuricemic model to oral administration with the PBS or WE respectively, and urine samples were collected to process urine uric acid (UUA) test after 30、90、150 and 210 mins. These tests of the efficiency for scavenge of DPPH and the ferric thiocyanate (FTC) have utilized different concentration of extractives belonging to 4 layers react with agents, and tested the absorption with 517 and 500 nm respectively. Crude extractives were divided into three groups. One was the control group (oral phosphate buffer). Second group was tested for oral consumption of 50 times the effective dosage of reducing plasma uric acid level (625 mg/kg) for 1~4 days during pregnancy. Third group was tested during 8~11 days of pregnancy. Subacute toxicities were tested the consumption of the 10 times effective dosage of reducing plasma uric acid level (125 mg/kg) for 28 days and blood samples were collected to be conducted hematology, biochemistry and histology study.
The results of these studies indicated that T. albiflora can decrease the level of blood uric acid, these 4 different types of extractive had the same ability, but the WE had the best affect in last estimative point (240 min). These 4 different types of extractive can also inhibit the XO, and WE had the best efficacy. The result of eliminated uric acid test revealed that WE hadn’t affect to eliminate uric acid. The BE had better efficacy in the scavenge of DPPH testing and the FTC testing. The toxicological result showed that fertilized egg implantation rate, fetal organogenesis and resorption rate were not be impacted on the femate rat after oral administrateion with 50 times the effective dosage extractives of reducing plasma uric acid level (625 mg/kg) from the leaves of T. albiflora extractive during the pregnant period.The test of subacute toxicity revealed the Hb, HCT and RBC had significant increase (p＜0.05); the ALKP and BUN had significant decrease (p＜0.05) compared with control group.
This study has shown that T. albiflora can decrease the blood uric acid by inhibiting XO, and it also can eliminate free radical by preventing fatty oxidantion to achieve antioxidant. Female rat oral administrated high dosage during the period of pregnancy may not impact fertilized egg implantation, fetal organogenesis and resorption, but oral administrated T. albiflora for long and high dosage may cause hepatic cell swelling and slightly hyperplasia of bile duct, it could suggest that T. albiflora is not suitable to medicate in long and high dosage.

並列關鍵字

hyperuricemia ； xanthine oxidase inhibitor ； Tradescantia albiflora Kunth ； antioxidant

參考文獻

行政院衛生署。公告衛生署審核通過之健康食品一覽表。2004。

Lee W, Chen H, Wang W, Wei P, Lin C, Huang M. Metabolic syndrome in obese patients referred for weight reduction surgery in Taiwan. J Formos Med Assoc 102: 459-464, 2003.

Agudelo CA and Wise C. Crystal-associated arthritis. Clin Geriatr Med 14: 495-513, 1998.

Ames BN, Mccann J, Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat Res 6: 347-364, 1975.

Anker SD, Doehner W, Rauchhaus M, Sharma R, Francis D, Knosalla C, Davos CH, Cicoira M, Shamim W, Kemp M, Segal R, Osterziel KJ, Leyva F, Hetzer R, Ponikowski P, Coats AJ. Uric acid and survival in chronic heart failure: validation and application in metabolic, functional, and hemodynamic staging. Circulation 107: 1991-1997, 2003.